Accelmed is a growth-oriented investment firm specializing in HealthTech companies, leveraging proprietary technologies and data analysis to support clinical trials and patient care. Founded in 2009, the firm manages private equity funds and invests in commercial-stage companies, with notable achievements in digital therapeutics and medical device sectors.
Recent Transactions involving Accelmed
| Deal | Target | Platform | Buyer | Industry |
|---|---|---|---|---|
Veranex Acquires Leading Preclinical Services Provider T3 Labs |
T3 Labs |
Veranex |
Summit PartnersLauxera Capital PartnersAccelmed |
Medical Equipment Manufacturing |
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →